ACN Newswire
Read More

HG Semiconductor Enters into Strategic Cooperation Framework Agreement with the Family Trust of GCL Technology Founder Mr. Zhu Gongshan

indie
4 minutes

HONG KONG, Sep 8, 2022 - (ACN Newswire via SEAPRWire.com) - HG Semiconductor Limited ("HG Semiconductor", together with its subsidiaries, "the Group", Stock Code: 6908.HK) is pleased to announce that the Group entered into a strategic cooperation framework agreement (the "Strategic Cooperation Framework Agreement") on 7 September 2022 with Golden Concord Group Limited ("Golden Concord Group"), a company ultimately held under a discretionary trust (the "Investor Family Trust") with Founder, Chairman and Executive Director of GCL Technology Holdings Limited ("GCL", Stock Code: 3800.HK) Mr. Zhu Gongshan (the "Investor" or "Mr. Zhu") and his family members as beneficiaries. Pursuant to the Strategic Cooperation Framework Agreement, the Group and Golden Concord Group (collectively, the "Parties") intend to initiate close cooperation in application of gallium nitride ("GaN") power chips in the field of new energy, including (i) Golden Concord Group or its subsidiaries will be involved in equity of the Group or its subsidiaries to establish in-depth cooperation; (ii) the Parties will establish a domestic new energy joint venture (the "JV Company") to tap into application of GaN chips in t...

ACN Newswire
Read More

The Golden Duck’s Savoury Snacks to Debut in Malaysian Physical Stores

indie
2 minutes

KUALA LUMPUR, May 30, 2022 - (ACN Newswire via SEAPRWire.com) - Malaysians should brace themselves for more-ish savoury snacks as Singapore's The Golden Duck Co., purveyor of delicious fish skin crisps and potato wedges coated in salted egg yolk, is finally available in physical stores in the country now.The Golden Duck, founded by Mr. Jonathan Shen and Mr. Christopher Hwang in 2015, has since 2018 become one of the leading savoury brands in Singapore, where it is available at most major retailers in multiple locations as well as online in 15 countries including China, Mauritius, The Philippines, Australia, United States, Qatar and the Kingdom of Saudi Arabia.Jonathan, co-founder of The Golden Duck, said, "We are really excited that our products will now be available in physical stores in Malaysia. We know many Malaysians are familiar with the taste of our products and now they can easily buy it off the shelves and online when they have the cravings."The Golden Duck had debuted in November 2015 in a pop-up store in a mall and very quickly gathered a following, with the popularity of their salted egg yolk-coated potato wedges prompting the duo to limit purchases to five bags per cus...

ACN Newswire
Read More

SinoMab Awared the “Best Small and Mid-Cap Company” and “Best CEO” in the Selection of the “6th Hong Kong Golden Stocks Awards” and the “Listed Company with the Most Growth Potential” in the Selection of “2021 Sina Finance Golden Unicorn Best Hong Kong and US Listed Companies”

indie
4 minutes

HONG KONG, Jan 11, 2022 - (ACN Newswire via SEAPRWire.com) - SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group", stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, was awarded the "Best Small and Medium-Cap Company" at the "6th Hong Kong Golden Stocks Awards Ceremony" held in Shenzhen today, and Dr. Shui On LEUNG, Executive Director, Chairman and Chief Executive Officer of the Company, was awarded the "Best CEO". The Company was also previously awarded the "Listed Company with Most Growth Potential" in the selection of "2021 Sina Finance Golden Unicorn Best Hong Kong and US Listed Companies".The Company awarded the "Best Small and Medium-Cap Company"Dr. Shui On LEUNG, Executive Director, Chairman and Chief Executive Officer of the Company, was awarded the "Best CEO"SinoMab completed enrollment in the phase III clinical trial of its flagship product, SM03, in November last year and expects to commercialize SM03 soon after the clinical data readout this year. In addition, SN1011, a key ...